The Cordyceps Genus as a Potential Source of Bioactive Compounds for Adjuvant Cancer Therapy: A Network Pharmacology Approach.

Ophiocordyceps sinensis

OncologyEnergy & fatigueRespiratory

SpeciesCordyceps, Caterpillar Fungus

JournalPharmaceuticals (Basel, Switzerland)

Year2025

Metadata-grounded summary

Article summary

Metadata-grounded summary: This research article indexes research on Ophiocordyceps sinensis in Pharmaceuticals (Basel, Switzerland) in 2025. MycoData maps the paper to oncology, energy & fatigue, respiratory based on its title, species context, article metadata, and study classification.

Citation

Gonzalez-Llerena JL, Treviño-Almaguer D, Leal-Mendez JA, Garcia-Valdez G, Balderas-Moreno AG, Heya MS, et al. (2025). The Cordyceps Genus as a Potential Source of Bioactive Compounds for Adjuvant Cancer Therapy: A Network Pharmacology Approach. Pharmaceuticals (Basel, Switzerland) https://doi.org/10.3390/ph18050667 PMID: 40430485

Open citation